Work

Efficacy and Safety of Single-Agent Pertuzumab, a Human Epidermal Receptor Dimerization Inhibitor, in Patients with Non–Small Cell Lung Cancer

Year: 2007

Type: article

Study design: Clinical Trial

Source: Clinical Cancer Research

DOI: 10.1158/1078-0432.ccr-07-0460

Authors: Roy S. Herbst, Angela M. Davies, Ronald B. Natale, Thao P. Dang, Joan H. Schiller, Linda L. Garland, Vincent A. Miller, David Mendelson, Annick D. Van den Abbeele, Yulia Melenevsky, Daniel J. de Vries, David A. Eberhard, Benjamin Lyons, Stuart G. Lutzker, Bruce E. Johnson

Institutions: The University of Texas MD Anderson Cancer Center, UC Davis Comprehensive Cancer Center, University of California, Davis, Cedars-Sinai Medical Center, Vanderbilt University, Vanderbilt-Ingram Cancer Center, University of Wisconsin–Madison, Memorial Sloan Kettering Cancer Center, Pinnacle Oncology Hematology, Dana-Farber Cancer Institute, Genentech

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Cancer Institute

OpenAlex ID: W2008166288

FWCI: 8.271

Cites: 43

Cited by: 102

Related to: 10